This theory stems from the latest descriptions of tau pathology in IgLON5-Ab disease, as previously mentioned, and from a recent observation of AD intermediate pathology and brain positron-emission tomography (PET) tau accumulation in LGI1-Ab patients [131]. This evidence concerns the gene MAPT and Alzheimer disease.